MyFinsight
Home
Blog
About
Back
Income Statement
20 20 Biolabs, Inc. (AIDX)
20 20 Biolabs, Inc. (AIDX)
source: myfinsight.com
Net loss
attributable to common...
-$2,752,681
Net loss
-$1,506,343
Deemed dividend on
warrant modifications
$1,124,676
Preferred stock dividends
$121,662
Revenues
$730,571
Operating loss
-$1,244,223
Total other (expense)
income
-$262,120
Gross profit
$304,727
Interest income
$14,476
Cost of revenues
$425,844
Total operating
expenses
$1,548,950
Interest expense
$272,245
Loss on issuance of
convertible note
-$4,236
Other expense, net
-$115
Sales, general and
administrative
$1,291,318
Research and development
$257,632
Back